Trinity Biotech (TRIB) Profit After Tax Growth (3y) (2012 - 2024)
Trinity Biotech (TRIB) Profit After Tax Growth (3y) (2012 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.57 Bn | 193.97 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 127.25 Bn | 123.77 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 118.81 Bn | 109.59 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.28 Bn | 32.34 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.64 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 15.46% |
| 10 | Trinity Biotech | 6.81 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -136.46% |
| Sep 30, 2024 | -76.79% |
| Jun 30, 2024 | -105.11% |
| Mar 31, 2024 | -34,955.13% |
| Dec 31, 2023 | -22,447.23% |
| Sep 30, 2023 | -42.89% |
| Jun 30, 2023 | -63,895.26% |
| Mar 31, 2023 | -38,935.50% |
| Dec 31, 2022 | -20,954.53% |
| Sep 30, 2022 | -215,257.26% |
| Jun 30, 2022 | -23.24% |
| Mar 31, 2022 | -295.67% |
| Dec 31, 2021 | 63.21% |
| Sep 30, 2021 | 46.88% |
| Jun 30, 2021 | -30,252.97% |
| Mar 31, 2021 | 62.33% |
| Dec 31, 2020 | 99.78% |
| Sep 30, 2020 | 126.79% |
| Jun 30, 2020 | -25.99% |
| Mar 31, 2020 | -57.31% |